Stay updated on Ibrutinib-Nivolumab Combo in Hematologic Malignancies Clinical Trial

Sign up to get notified when there's something new on the Ibrutinib-Nivolumab Combo in Hematologic Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ibrutinib-Nivolumab Combo in Hematologic Malignancies Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.2 to v3.6.3. This reflects a new site release rather than a change to study content.
    Difference
    0.0%
    Check dated 2026-07-03T22:09:30.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The page's revision tag has been updated to v3.6.2, indicating a newer version of the page. The update does not change study details or user-facing information.
    Difference
    0.0%
    Check dated 2026-06-26T23:54:18.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The study record now shows that recruitment is closed and no longer looking for participants. New sections for How to Read a Study Record, Common Questions, and How to Join a Study were added, and the Intervention/Treatment heading was reformatted.
    Difference
    0.4%
    Check dated 2026-06-12T14:18:12.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.5.5 instead of Revision: v3.5.4. This reflects a minor site revision rather than changes to the study details.
    Difference
    0.0%
    Check dated 2026-06-05T10:37:15.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.3 to v3.5.4, indicating a newer version of the page content. The change does not affect the study details displayed.
    Difference
    0.0%
    Check dated 2026-05-14T23:26:42.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Revision updated to v3.5.3, replacing the previous v3.5.2. This represents a minor documentation/versioning update and does not change study details or eligibility content.
    Difference
    0.0%
    Check dated 2026-04-30T17:27:24.000Z thumbnail image

Stay in the know with updates to Ibrutinib-Nivolumab Combo in Hematologic Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ibrutinib-Nivolumab Combo in Hematologic Malignancies Clinical Trial page.